ARVINAS, INC. — Investor Relations & Filings
Arvinas, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics based on targeted protein degradation. The company is a leader in this field, utilizing its proprietary PROTAC® (PROteolysis TArgeting Chimera) platform to create a new class of drugs. This technology is designed to harness the body's own cellular machinery to selectively remove disease-causing proteins. Arvinas is advancing a pipeline of investigational therapies targeting debilitating and life-threatening diseases, with a primary focus on oncology and neuroscience. The company was the first in its field to advance an investigational drug through a pivotal trial and submit a New Drug Application to U.S. regulators.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - ARVINAS, INC. (0001655759) (Filer) | 2026-05-12 | English | |
| 8-K - ARVINAS, INC. (0001655759) (Filer) | 2026-05-12 | English | |
| 10-Q - ARVINAS, INC. (0001655759) (Filer) | 2026-05-11 | English | |
| 8-K - ARVINAS, INC. (0001655759) (Filer) | 2026-05-01 | English | |
| ARS - ARVINAS, INC. (0001655759) (Filer) | 2026-04-29 | English | |
| DEF 14A - ARVINAS, INC. (0001655759) (Filer) | 2026-04-29 | English |
Browse filings by year
10 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biomark Diagnostics Inc.
Oncology liquid biopsy diagnostics using metabolomics and A…
|
BUX | CA | Professional, scientific and te… |
|
Biomind Labs
Developing novel pharmaceutical drugs for patients with neu…
|
BMND | CA | Professional, scientific and te… |
|
BioNexus Gene Lab Corp
Develops gene-based diagnostics for early detection of dise…
|
BGLC | US | Professional, scientific and te… |
|
Biophytis S.A.
Clinical-stage biotech developing therapeutics for age-rela…
|
ALBPS | FR | Professional, scientific and te… |
|
BioRestorative Therapies, Inc.
Develops adult stem cell therapies for degenerative disc an…
|
BRTX | US | Professional, scientific and te… |
|
BioSenic SA
Develops therapies for autoimmune diseases, inflammation, a…
|
BIOS | BE | Professional, scientific and te… |
|
BIOTECH
A biotechnology group offering preclinical services, intein…
|
BST | ES | Professional, scientific and te… |
|
BIOTRON LIMITED
Clinical-stage developer of small molecule antiviral drugs …
|
BIT | AU | Professional, scientific and te… |
|
BioVaxys Technology Corp.
Clinical-stage biopharma developing novel immunotherapy ass…
|
BIOV | CA | Professional, scientific and te… |
|
Biovica International B
Develops blood-based biomarker assays for cancer therapy mo…
|
BIOVIC | SE | Professional, scientific and te… |
ARVINAS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32625/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32625 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32625 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32625 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32625}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ARVINAS, INC. (id: 32625)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.